PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
批准号:
6384525
负责人:
Om Prakash Srivastava
金额:
$21.53万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-07-01 至 2004-04-30
关键词:
SDS polyacrylamide gel electrophoresis aging cataract crosslink crystallins endopeptidases enzyme substrate gel filtration chromatography glycation high performance liquid chromatography human tissue immunoprecipitation membrane proteins pathologic process posttranslational modifications protease inhibitor protein sequence proteolysis radioimmunoassay western blottings
中文摘要
描述:蛋白质的修饰在正常晶状体转变为白内障晶状体的过程中起着关键作用。内源性酶对晶体蛋白中肽键的蛋白水解裂解可能是最常见和最重要的修饰之一。到目前为止,关于晶体蛋白中这些裂解的信息仅限于它们的酶性质、在酶和底物水平上的调控、对晶体蛋白功能的影响以及晶体蛋白片段的二次修饰。基于初步结果,P.I.假设晶体蛋白的降解在酶和底物水平上都受到调节,被切割的片段通过Mail猪油反应进行二次修饰,如糖基化,因此直接参与晶体蛋白的交联,这是晶体不透明形成的核心。为了验证这一假设,将追求以下三个特定目标:(1)特定目标#1:从假定的ba31a1 -结晶蛋白蛋白酶的酶原型激活中确定膜蛋白酶的自溶激活机制,如脱氧胆酸钠洗涤剂。(2)特异性目的#2:确定膜蛋白酶和ba31a1 -晶体蛋白蛋白酶在选定晶体蛋白体内蛋白水解中的作用。(3)具体目标#3:确定降解多肽的交联,特别是9 kDa的yd -晶体蛋白片段,形成同源(晶体蛋白片段单独)和异源(晶体蛋白片段加天然晶体蛋白)多聚体,可能通过美拉德反应的糖基化机制。上述研究将解决晶体蛋白降解的体内调控以及内源性蛋白酶在这一过程中的作用等问题。本研究还将回答降解多肽在二次修饰下是否获得交联性质并直接参与晶状体混浊发展过程中的蛋白质交联的问题。由于所有拟议的研究都将在人体晶状体上进行,因此其结果将与人类老年性白内障问题直接相关。
英文摘要
DESCRIPTION: Modification of proteins play a pivotal role in changing a normal lens into a cataractous lens. Proteolytic cleavage of peptide bonds in crystallins by endogenous enzymes is probably one of the most frequent and important modifications. So far, information about these cleavages in crystallins is limited in terms of their enzymatic nature, regulation at the enzyme and substrate levels, effect on crystallin functions and secondary modifications in crystallin fragments. Based on preliminary results, the P.I. has hypothesized that the degradation of crystallins is regulated at both enzyme and substrate levels and the cleaved fragments undergo secondary modification such as glycation via the Mail lard reaction and therefore directly participate in the cross-linking of the lens proteins which is central to the development of lens opacity. To test this hypothesis, the following three specific aims will be pursued: (1) specific Aim #1: Determine the mechanism of autolytic activation of a membrane proteinase from a putative zymogen type activation of the BA31A1-crystallin proteinase by a detergent such as sodium deoxycholate. (2) specific Aim #2: Determine the role of the membrane proteinase and BA31A1-crystallin proteinase in the in vivo proteolysis of selected crystallins. (3) Specific Aim #3: Determine crosslinking of degraded polypeptides in general and specifically of a 9 kDa yD-crystallin fragment to form homologous (crystallin fragments alone) and heterologous (crystallin fragments plus native crystallins) multimers possibly via the glycation mechanism of the Maillard reaction. The above studies will address the questions regarding the in vivo regulation of crystallin degradation and the role of endogenous proteinases in this process. This study will also answer the questions whether the degraded polypeptides, on secondary modifications, acquire cross-linking properties and participate directly in protein cross-linking during the development of lens opacity. Since all of the proposed studies will be carried out in human lenses, the results will be directly relevant to the human senile cataract problem.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanism of αAN101D-Transgene-Induced Age-Related Cataract
-
批准号:10597653
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2020
-
负责人:Om Prakash Srivastava
-
依托单位:
Molecular Mechanism of αAN101D-Transgene-Induced Age-Related Cataract
-
批准号:10376357
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2020
-
负责人:Om Prakash Srivastava
-
依托单位:
CORE--COMPUTER
-
批准号:6325810
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2000
-
负责人:Om Prakash Srivastava
-
依托单位:
CORE--COMPUTER
-
批准号:6192093
-
项目类别:
-
资助金额:$10.18万
-
财政年份:1999
-
负责人:Om Prakash Srivastava
-
依托单位:
SMALL INSTRUMENTATION GRANT
-
批准号:2165066
-
项目类别:
-
资助金额:$0.9万
-
财政年份:1994
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:6131752
-
项目类别:
-
资助金额:$24.03万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:6518358
-
项目类别:
-
资助金额:$25.58万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhbitors & Crystallin Fragments in Cataract
-
批准号:7115412
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhibitors and Crystallin Fragments in Cataract
-
批准号:8370202
-
项目类别:
-
资助金额:$36.63万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhbitors & Crystallin Fragments in Cataract
-
批准号:7399654
-
项目类别:
-
资助金额:$5.35万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Project title Proteinase Inhibitors & Crystallin Fragments in Cataract
-
批准号:7654940
-
项目类别:
-
资助金额:$36.58万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE, INHIBITOR & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2160129
-
项目类别:
-
资助金额:$12.91万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhbitors & Crystallin Fragments in Cataract
-
批准号:6921646
-
项目类别:
-
资助金额:$32.21万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:6890150
-
项目类别:
-
资助金额:$1.45万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhbitors & Crystallin Fragments in Cataract
-
批准号:7032943
-
项目类别:
-
资助金额:$31.97万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhibitors and Crystallin Fragments in Cataract
-
批准号:8514613
-
项目类别:
-
资助金额:$34.79万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
Proteinase Inhibitors and Crystallin Fragments in Cataract
-
批准号:8857466
-
项目类别:
-
资助金额:$35.89万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2444292
-
项目类别:
-
资助金额:$12.54万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2710917
-
项目类别:
-
资助金额:$13.04万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
PROTEINASE INHIBITORS & CRYSTALLIN FRAGMENTS IN CATARACT
-
批准号:2160133
-
项目类别:
-
资助金额:$14.71万
-
财政年份:1993
-
负责人:Om Prakash Srivastava
-
依托单位:
海外基金